» Articles » PMID: 21069422

Cell-specific and Hypoxia-dependent Regulation of Human HIF-3α: Inhibition of the Expression of HIF Target Genes in Vascular Cells

Overview
Publisher Springer
Specialty Biology
Date 2010 Nov 12
PMID 21069422
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia-inducible factors (HIF) are transcription factors responding to reduced oxygen levels and are of utmost importance for regulation of a widespread of cellular processes, e.g., angiogenesis. In contrast to HIF-1α/HIF-2α, the relevance of HIF-3α for the regulation of the HIF pathway in human vascular cells is largely unknown. HIF-3α mRNA increases under hypoxia in endothelial and vascular smooth muscle cells. Analysis of HIF-3α isoforms revealed a cell type-specific pattern, but only one isoform, HIF-3α2, is hypoxia-inducible. Reporter gene assays of the appropriate promoter localized a 31-bp fragment, mediating this hypoxic regulation. The contribution of HIF-1/2 and NFκB to the HIF-3α induction was verified. Functional studies focused on overexpression of HIF-3α isoforms, which decrease the hypoxia-mediated expression of VEGFA and Enolase2. These data support the notion of a hypoxia-induced inhibitory function of HIF-3α and demonstrate for the first time the existence of this negative regulation of HIF-signaling in vascular cells.

Citing Articles

Protein kinase B/AKT phosphorylates hypoxia-inducible factor-3α1 in response to insulin, promoting cell growth and migration.

Nguyen T, Bergmann U, Kietzmann T, Mennerich D Front Cell Dev Biol. 2023; 11:1250000.

PMID: 38020884 PMC: 10665492. DOI: 10.3389/fcell.2023.1250000.


Mechanism of HIFs in osteoarthritis.

Zhang X, Kong H Front Immunol. 2023; 14:1168799.

PMID: 37020556 PMC: 10067622. DOI: 10.3389/fimmu.2023.1168799.


Regulation of Transactivation at C-TAD Domain of HIF-1 by Factor-Inhibiting HIF-1 (FIH-1): A Potential Target for Therapeutic Intervention in Cancer.

Rani S, Roy S, Singh M, Kaithwas G Oxid Med Cell Longev. 2022; 2022:2407223.

PMID: 35592530 PMC: 9113874. DOI: 10.1155/2022/2407223.


Hypoxia-inducible factor (HIF)-3a2 serves as an endothelial cell fate executor during chronic hypoxia.

Jaskiewicz M, Moszynska A, Serocki M, Kroliczewski J, Bartoszewska S, Collawn J EXCLI J. 2022; 21:454-469.

PMID: 35391921 PMC: 8983852. DOI: 10.17179/excli2021-4622.


Regulation of the Hypoxia-Inducible Factor (HIF) by Pro-Inflammatory Cytokines.

Malkov M, Lee C, Taylor C Cells. 2021; 10(9).

PMID: 34571989 PMC: 8466990. DOI: 10.3390/cells10092340.


References
1.
Bjornheden T, Levin M, Evaldsson M, Wiklund O . Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol. 1999; 19(4):870-6. DOI: 10.1161/01.atv.19.4.870. View

2.
Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996; 16(9):4604-13. PMC: 231459. DOI: 10.1128/MCB.16.9.4604. View

3.
Hara S, Hamada J, Kobayashi C, Kondo Y, Imura N . Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem Biophys Res Commun. 2001; 287(4):808-13. DOI: 10.1006/bbrc.2001.5659. View

4.
Maynard M, Evans A, Hosomi T, Hara S, Jewett M, Ohh M . Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J. 2005; 19(11):1396-406. DOI: 10.1096/fj.05-3788com. View

5.
Willert M, Augstein A, Poitz D, Schmeisser A, Strasser R, Braun-Dullaeus R . Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation. Basic Res Cardiol. 2009; 105(2):267-77. DOI: 10.1007/s00395-009-0055-x. View